SPOTLIGHT: Drug industry faces tough challenges in coming years


It's looking like the next few years will be tough for the pharmas, with top-selling drugs going off-patent, and generics cutting $67 billion from annual sales between 2007 and 2012. Meanwhile, with fewer drugs coming available, new sources of revenue are comparatively scarce. To address these looming threats, expect to see the industry transform itself in coming years, observers say. FiercePharma

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.